CRMD FY 2024 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$43M

Gross Profit

$40M92.7% margin

Operating Income

-$22M-51.4% margin

Net Income

-$18M-41.2% margin

EPS (Diluted)

$-0.30

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$51M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$119M

Total Liabilities

$34M

Stockholders' Equity

$85M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43M	$0	—
Gross Profit	$40M	-$205,562	+19695.9%
Operating Income	-$22M	-$49M	+54.3%
Net Income	-$18M	-$46M	+61.3%